marijuana stocks news

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

ITEM 1.01 Entry Into a Material Definitive Agreement
The Company has cancelled 5,124,923 shares of common stock of the company, under 4 separate agreements.

On January 17, 2017 the Company returned to treasury 1,700,000 shares of common stock under a settlement agreement with the previous owners of Vapolution, Inc., (“Vapolution”). MCIG elected to close the operation as a standalone entity and terminate its cost basis investment. The Company will continue selling the Vapolution brand products under MCIG.

On January 31, 2017, in settlement of services provided, the Company cancelled 2,560,336 shares of common stock by two shareholders who obtained the stock as stock based compensation. The company recorded a reduction of stock based compensation based upon the issue price (cost basis), not current market price. The cost basis of the agreements was $47,472.

On February 13, 2017, in settlement of services provided, the Company cancelled 964,587 shares of common stock by a shareholder who obtained the stock as stock based compensation. The company recorded a reduction of stock based compensation based upon the issue price (cost basis), not current market price. The cost basis of the agreements was $36,000.

ITEM 9.01 Financial Statements and Exhibits.
Exhibit No. Description

10.1 Form of Rescission Agreement and Mutual Release


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$LXRP Bioavailability Testing to Commence on Patent-Pending Technology

Bioavailability Testing to Commence on Lexaria’s Patent-Pending Technology Lexaria Corp. (LXRP) (CSE:LXX)…

Neptune Wellness Solutions Inc. (NEPT) Announces Letter of Intent to Acquire Leading Data-Marketing and Artificial Intelligence Company

Neptune Wellness Announces Letter of Intent to Acquire Leading Data-Marketing and Artificial…

AbbVie Inc. (ABBV) and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma

AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma…

MariMed Inc. (MRMD) Announces Fourth Quarter 2022 Earnings Date

MariMed Announces Fourth Quarter 2022 Earnings Date MariMed Inc. (“MariMed” or the…